SCHEMBL24536418

SCHEMBL24536418

CCN1C[C@@H](NC)[C@H](NC(C)C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23054423 1.00 — —
SCHEMBL21423721 1.00 — —
SCHEMBL21424040 1.00 — —
SCHEMBL23750317 0.85 — —
SCHEMBL24536450 0.82 — —
SCHEMBL22920432 0.79 GBA1 (0.35) —
SCHEMBL21424190 0.79 GBA1 (0.35) —
SCHEMBL21424123 0.79 GBA1 (0.35) —
SCHEMBL23054500 0.79 GBA1 (0.35) —
SCHEMBL22920502 0.79 GBA1 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022133034-A1 METHODS OF TREATING DISORDERS ASSOCIATED WITH CASTOR ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. (US) 2022-06-23 — — WO disclosed
Send feedback